LINC00994: A Drug Target / Disease Biomarker (G100287879)

Target Name: LINC00994

NCBI ID: G100287879

LINC00994

Other Name(s): Long intergenic non-protein coding RNA 994 | long intergenic non-protein coding RNA 994

LINC00994: A Drug Target / Disease Biomarker

LINC00994 is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the LINC subfamily of RNA-binding proteins, which are known for their ability to interact with RNA molecules. LINC00994 is primarily localized to the cytoplasm of cells, and its function is not well understood.

One possible function of LINC00994 is as a drug target or biomarker. It is possible that LINC00994 may be targeted by small molecules or other compounds that are designed to interact with its unique protein structure. If this is the case, LINC00994 could potentially be used to diagnose or treat a variety of diseases.

Additionally, LINC00994 may also be used as a biomarker to monitor the effectiveness of certain treatments. For example, if a patient is being treated for a particular disease, the levels of LINC00994 in their body could be monitored to determine if the treatment is having the desired effect. This could be a valuable tool for doctors to use in the treatment of disease.

Overall, LINC00994 is a protein that is still being studied, and its full function and potential uses are not yet fully understood. Further research is needed to determine the exact role of LINC00994 in the body and its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 994

The "LINC00994 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00994 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets